Golden Leaf Holdings Ltd (OTCMKTS:GLDFF) seeks legal action against Peter Saladino and BMF Washington LLC to recover damages of $6.917 million. The company is claiming the damages for improper use of intellectual property and equipment. It also said seeking damages against BMF and its owner for trade secrets misappropriation.
Introduces RXO product line
Golden Leaf has introduced RXO product line that comprises an ultra-pure pharmaceutical grade, a variant of Rick Simpson cannabis oil extract. The company entered a pact with Real Solutions Organization for creating the RXO product line of Chalice Farms. It has used Essential Innovations Patented Technology to produce full-spectrum extract focused products in several consumption methods that include liquid concentrate for oral consumption, pre-filled vape cartridges, and concentrated cannabis shatter for dabbing.
After launching the RXO product line in December 2019 in Oregon, Golden Leaf plans to introduce in Nevada in Q1 2020. Chief Executive Officer of Golden Leaf, Jeff Yapp, said the company created the RXO product line for patients and consumers to enjoy highly potent and pure extracts without any adverse effects on health. He further said the products are offered in multiple consumption methods to maximize wellness to health-conscious audience.
Matt Steele, President, and Co-founder of Real Solutions said the full spectrum oil in the RXO product line is a blend of natural ingredients and improves therapeutic value. He is pleased to play a vital role in providing high-quality products to the communities.
Organic grain ethanol-based extraction
Golden Leaf used the organic grain ethanol-based extraction method as well as the equipment for creating an extract in RXO products. The RXO products comprise a pure and cleaner cannabis concentrates when compared to other RSO products available in the market. It also comprises fatty acids, phenols, flavonoids, cannabinoids, and terpenes. Therefore, RXO is safe and ideal for smokable, topical, and edible delivery options.
Divests Medical Marihuana Group Corp
Golden Leaf has divested its two subsidiaries – Medical Marijuana Group Consulting Ltd and Medical Marihuana Group Corporation, which are based in Canada, for $3.4 million. Following the sale, the Golden Leaf will strengthen the cash position. It also retains the right to market Chalice Farm products.
Bhang Inc (OTCMKTS: BHNGF) Allowed Administration Stop Trade Directive
Bhang Inc (OTCMKTS: BHNGF), a worldwide cannabis CPG brand company with an award-winning collection of merchandises, proclaimed today that the Ontario Securities Commission had granted the Company’s application for an administration stop trade order under National Policy 12-203 – Management Cease Trade Orders (the “MCTO”). As beforehand proclaimed, the Company made the application for the MCTO in association with the expected postponement in the recording of its monetary declarations for the year over December 31, 2020, and the connected management’s dialogue and analysis and certifications.
As beforehand revealed, the Company needs extra time to finalize the Annual Filings and is effecting with its auditors to finalize the audit of the Company’s annual monetary declarations and file the Annual Filings by May 2021.
During the passé during which the MCTO is in effect, the general participating public will endure trade in the Company’s secondary voting stocks. Though, for the length of the MCTO, the Company’s Chief Executive Officer and Chief Financial Officer will not be able to trade any Corporation’s securities. The Company has also enforced a trading embargo on its directors and officers until the filing of the Annual Filings and the Company’s temporary monetary declarations and connected management’s confab and study and guarantees for the period ended March 31, 2021.
The Company will obey the Alternative Information Guidelines set out in National Policy 12-203 for so long as it endures to evasion of the obligation to file the Annual Filings. The Company confirms that since the date of its tender for the MCTO on April 19, 2021
1.There has been no physical alteration to the info set out in the MCTO Notice that has not been usually revealed.
- There has been no letdown by the Company in satisfying its stated meanings with admiration to sustaining the necessities of the alternative information rules set out in NP 12-203.
- There has not been any other stated evasion by the Company under NP 12-203.
- There is no other material info regarding the matters of the Company that has not been usually revealed.
The MCTO will remain in effect until the Company records the Yearly Filings and Temporary Filings and the MCTO is annulled.
Bhang Inc is dedicated to making the fairly pleasant ludicrously fun. For over a decade, Bhang has transported excellent sensual involvements to customers through its widespread collection of over 50 master-chef-shaped cannabis, CBD and terpene merchandise.
Agraflora Organics International Inc (OTCMKTS: AGRA) Speaks Of Fiona Fitzmaurice’s Appointment As The New Chief Financial Officer (“CFO”)
Fiona Fitzmaurice has been appointed the new Chief Financial Officer in Agraflora Organics International Inc (OTCMKTS: AGRA). The leader’s appointment was subject to the Canadian Securities Exchange’s final acceptance, and the company hopes to benefit significantly from Fiona’s professionalism in accountancy.
Fitzmaurice is a great addition to the company
The company considered several factors before making its final appointment decision. On top of the list was the fact that she was a Chartered Professional Accountant. Her experience spanned about 14 years where she served in accounting and financial control positions. She has had the opportunity to work with some of the major public and private companies, and that has contributed to significant growth in her career experience.
Peter Nguyen has been serving AgraFlora as the CFO, and he stepped out amicably to give room to the new official to propel the company to new heights.
The CEO of AgraFlora Elise Coppens opined, “On behalf of the Board of Directors, I am pleased to welcome Fiona to AgraFlora’s management team as we continue to evolve the Company’s streamlined corporate strategy and execute on our near-term goal of generating revenues from our core assets.”
Coppens thanks Peter for the major contributions he has made towards the growth of the company. The CEO terms the leader’s exit as a professional one, wishing him the best of luck in his future endeavors.
Axim Biotechnologies Inc (OTCMKTS: AXIM) has on the other hand discloses details about Empowered Diagnostics and its latest move. Empowered Diagnostics happens to be its manufacturing partner. Empowered Diagnostics wants to use its rapid test, but it must first and foremost gain approval from Health Canada. It is the reason the company has taken to file for the ImmunoPass™ emergency approval. It must fulfill the required conditions such as environmental protection and engage in the sale of ImmunoPass™.
Cannabix Technologies Inc (OTCMKTS: BLOZF) Collects Notification of Allowance for Discovery of Particles – F.A.I.M.S. U.S. Patent
Cannabix Technologies Inc (OTCMKTS: BLOZF) is designer of the Cannabix Marijuana Breathalyzer expedients for law implementation and the place of work, reports that it has obtained a notice of allowance from the United States Patent and Trademark Office (USPTO) for patent request, No. 17/019728 titled, “Device and Approaches for Discovery of Particles.” This Track 1 patent submission is aligned on novelties made by Cannabix with its F.A.I.M.S. (asymmetric field waveform ion mobility spectrometry) founded marijuana Breathalyzer know-how.
This patent request concludes the research and development effort directed by Cannabix experts and engineers in the zones of ion mobility spectrometry, non-volatile molecule specimen, and fluid subtleties. These growths will provide usefulness in numerous parts connected to the discovery of particles in a sniff. Cannabix uses its F.A.I.M.S. expertise to segregate and perceive ∆9-tetrahydrocannabinol (“T.H.C.”), a non-volatile composite, in a sniff.
The Cannabix F.A.I.M.S. marijuana Breathalyzer expedient uses ion flexibility sifting methods. The Cannabix expedient has been planned and built in a sequence of components that permit sample consumption, ionization, sifting, and discovery – all done under atmospheric heaviness. In addition, the expedient has the aptitude for combining straight to a mass spectrometer in instruction to authenticate its sensor replies. It should be mentioned that a notice of allowance
from the USPTO does not institute a grant of patent. The Company will report on upcoming material growths concerning its “Device and Approaches for Discovery of Particles” patent submission in due progression.
The Company has been progressively developing its intellectual property (I.P.) collection over recent months. In April, the Company obtained a notice of allowance for its patent application, No. 2887841 titled “Cannabis Drug Detection Device” from the Canadian Intellectual Property Office (C.I.P.O.). In addition, the Company was accorded a patent No. 14/689434 titled “Cannabis Drug Detection Device” from the USPTO in January 2021.
The Company supposes to ship its T.H.C.B.A. to surgery in the Northwestern, U.S.U.S. for beta analysis in May. The cooperating clinic has a healthy drug testing process and is one of the top drug analysis suppliers to businesses within its state. The beta analysis is absorbed in refining user knowledge through analysis and response and training the Device’s machine learning catalog.
Cannabix Technologies Inc. is a Vancouver, B.C.-based Know-how Company, maturing implements for law implementation and the workplace to perceive T.H.C. in smell.